Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$915M |
| 2 |
Meta Platforms (Facebook)
META
|
+$693M |
| 3 |
Salesforce
CRM
|
+$618M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
Nike
NKE
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.51B |
| 2 |
Pfizer
PFE
|
+$1.43B |
| 3 |
UBS Group
UBS
|
+$588M |
| 4 |
HSBC
HSBC
|
+$537M |
| 5 |
Procter & Gamble
PG
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.07% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Financials | 10.93% |
| 4 | Healthcare | 10.39% |
| 5 | Communication Services | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Nuveen ESG High Yield Corporate Bond ETF
NUHY
$111M
| $395K | ﹤0.01% |
17,725
| – | – |
|
577
Cognizant
CTSH
$26B
| $394K | ﹤0.01% |
8,489
+5,089
| +150% | +$303K |
|
|
ATVI
578
DELISTED
Activision Blizzard
ATVI
| $383K | ﹤0.01% |
6,444
-597
| -8% | -$35.4K |
|
579
Wynn Resorts
WYNN
$10.6B
| $382K | ﹤0.01% |
6,340
+90
| +1% | +$10.1K |
|
580
Kemper
KMPR
$1.68B
| $378K | ﹤0.01% |
+5,076
| New | +$380K |
|
581
SEI Investments
SEIC
$12.6B
| $371K | ﹤0.01% |
8,001
+3,117
| +64% | +$185K |
|
582
Gilead Sciences
GILD
$165B
| $364K | ﹤0.01% |
4,874
-500,913
| -99% | -$34.6M |
|
583
Amphenol
APH
$209B
| $357K | ﹤0.01% |
19,612
+204
| +1% | +$4.86K |
|
584
iShares MSCI Germany ETF
EWG
$1.62B
| $356K | ﹤0.01% |
16,580
-57,198
| -78% | -$1.52M |
|
585
Shopify
SHOP
$195B
| $352K | ﹤0.01% |
+8,450
| New | +$381K |
|
586
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
| $349K | ﹤0.01% |
3,301
-266
| -7% | -$29.1K |
|
587
CVS Health
CVS
$122B
| $349K | ﹤0.01% |
5,885
-10,652
| -64% | -$711K |
|
588
Automatic Data Processing
ADP
$108B
| $348K | ﹤0.01% |
2,548
-949
| -27% | -$153K |
|
589
Accenture
ACN
$108B
| $346K | ﹤0.01% |
2,120
-661
| -24% | -$127K |
|
|
AGN
590
DELISTED
Allergan plc
AGN
| $345K | ﹤0.01% |
+1,949
| New | +$367K |
|
591
iShares Core S&P Small-Cap ETF
IJR
$112B
| $333K | ﹤0.01% |
5,927
+631
| +12% | +$47K |
|
|
SGEN
592
DELISTED
Seagen Inc. Common Stock
SGEN
| $332K | ﹤0.01% |
2,875
-36
| -1% | -$3.99K |
|
|
PTLA
593
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $330K | ﹤0.01% |
46,245
-83
| -0.2% | -$1.04K |
|
594
Affiliated Managers Group
AMG
$9.76B
| $328K | ﹤0.01% |
5,551
-78
| -1% | -$5.84K |
|
595
iShares S&P 100 ETF
OEF
$20.6B
| $321K | ﹤0.01% |
2,705
+374
| +16% | +$51.5K |
|
596
Renasant Corp
RNST
$3.91B
| $321K | ﹤0.01% |
14,718
| – | – |
|
|
THS
597
DELISTED
Treehouse Foods
THS
| $319K | ﹤0.01% |
7,222
+100
| +1% | +$4.31K |
|
|
ACC
598
DELISTED
American Campus Communities, Inc.
ACC
| $317K | ﹤0.01% |
11,419
| – | – |
|
599
Ingersoll Rand
IR
$33.7B
| $316K | ﹤0.01% |
+12,739
| New | +$405K |
|
600
Henry Schein
HSIC
$9.82B
| $311K | ﹤0.01% |
6,147
-100
| -2% | -$6.34K |
|
Similar funds
Ken Fisher's Q1 2020 Portfolio in Review
As of Q1 2020, Ken Fisher held 982 positions worth $80.6B, down 19% from $99B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2020 filing shows 84 new, 262 increased, 421 reduced and 116 closed positions. Its largest new stake was Advanced Micro Devices: 7,132,669 shares worth $324M. The largest sale was Johnson & Johnson, an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Ken Fisher's largest Q1 2020 buy was Advanced Micro Devices: 7,132,669 shares worth $324M.
- Ken Fisher added most to Mastercard in Q1 2020, an estimated $915M increase.
- Ken Fisher's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $1.51B.
- Ken Fisher fully exited Ambev in Q1 2020, selling an estimated $89.9M.
- Ken Fisher's ten largest holdings make up 31% of its $80.6B portfolio in Q1 2020.
- Ken Fisher opened 84 new positions and closed 116 in Q1 2020.
- Ken Fisher's portfolio value fell 19% quarter-over-quarter to $80.6B.
Based on Fisher Asset Management's 13F filing for Q1 2020, filed 28 Apr 2020.